InvestorsHub Logo
Followers 0
Posts 5690
Boards Moderated 0
Alias Born 06/09/2012

Re: Rkmatters post# 68177

Monday, 08/01/2016 9:49:51 AM

Monday, August 01, 2016 9:49:51 AM

Post# of 704654
"There is no way they were going to disclose the proprietary method in the protocol! I repeat: No way!Here's more proof for you..." -RK

We have very different ideas on what constitutes proof ;)

Can't you simply call someone and get clarification? Get a hold of Bosch or Boynton or Liau or Prins some way? And ask them pointedly "I understand if you cannot reveal the exact method of manufacturing DCVax L, but is there no dedicated maturational step, just as there was none in the P1 study that combined DCVax L with TLR agonist or Imoquimod?"

I mean, that should clue you in anyway. IND 11053 has "no dedicated maturational step" but somehow IND 10206, which is earlier, does? And also includes BCG and/or INF-Y?

Heh :)


"Think for yourselves and let others enjoy the privilege to do so, too."

-Voltaire

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News